Exagen
Stock Forecast, Prediction & Price Target
Exagen (XGN) stock Price Target by analysts
$5
Potential downside: -48.24%
Exagen price prediction
What is Exagen stock analysts` prediction?
Exagen stock forecast: Based on 1 Wall Street analysts` predicted price targets for Exagen in the last 3 months, the avarage price target is $5, with a high forecast of $NaN. The average price target represents a -48.24% change from the last price of $9.66.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Exagen stock Price Target by analysts
Full breakdown of analysts given Exagen price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mark Massaro BTIG | 0% 0/1 | 10 months ago | $5 -48.24% downside | $2.79 | StreetInsider | Previous targets (0) |
Kyle Mikson Canaccord Genuity | 0% 0/1 | over 1 year ago | $5 -48.24% downside | $1.64 | StreetInsider | Previous targets (0) |
Unknown BTIG | N/A | almost 3 years ago | $7 -27.53% downside | $3.4 | Benzinga | N/A |
Exagen Financial Estimates
Exagen Revenue Estimates
Exagen EBITDA Estimates
Exagen Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $48.29M N/A | $45.56M -5.66% | $52.54M 15.33% | Avg: $64.76M Low: $64.00M High: $65.52M avg. 23.25% | Avg: $77.02M Low: $75.28M High: $79.56M avg. 18.92% | Avg: $87.5M Low: $85.52M High: $90.38M avg. 13.59% | Avg: $101M Low: $98.72M High: $104.32M avg. 15.42% |
Net Income
% change YoY
| $-26.85M N/A | $-47.38M -76.48% | $-23.68M 50.00% | Avg: $-17.56M Low: $-19.62M High: $-15.02M avg. 25.84% | Avg: $-15.85M Low: $-17.67M High: $-12.37M avg. 9.77% | Avg: $-15.02M Low: $-15.67M High: $-14.58M avg. 5.18% | Avg: $-11.49M Low: $-11.98M High: $-11.15M avg. 23.52% |
EBITDA
% change YoY
| $-24.05M N/A | $-39.71M -65.12% | $-19.15M 51.77% | Avg: $-30.03M Low: $-30.39M High: $-29.68M avg. -56.82% | Avg: $-35.72M Low: $-36.89M High: $-34.91M avg. -18.92% | Avg: $-40.58M Low: $-41.91M High: $-39.66M avg. -13.59% | Avg: $-46.84M Low: $-48.38M High: $-45.78M avg. -15.42% |
EPS
% change YoY
| -$1.68 N/A | -$2.77 -64.88% | -$1.34 51.62% | Avg: -$0.94 Low: -$1.11 High: -$0.85 avg. 29.70% | Avg: -$0.85 Low: -$1 High: -$0.7 avg. 9.76% | Avg: -$0.85 Low: -$0.89 High: -$0.83 avg. 0% | Avg: -$0.65 Low: -$0.68 High: -$0.63 avg. 23.52% |
Operating Expenses
% change YoY
| $51.77M N/A | $61.89M 19.53% | $52.29M -15.51% | Avg: $59.05M Low: $58.36M High: $59.75M avg. 12.93% | Avg: $70.23M Low: $68.65M High: $72.54M avg. 18.92% | Avg: $79.78M Low: $77.98M High: $82.41M avg. 13.59% | Avg: $92.09M Low: $90.02M High: $95.13M avg. 15.42% |
FAQ
What is Exagen stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.08% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -19.62M, average is -17.56M and high is -15.02M.
What is Exagen stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.80% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $64.00M, average is $64.76M and high is $65.52M.
What is Exagen stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.74% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.11, average is -$0.94 and high is $-0.85.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Exagen stock. The most successful analyst is Mark Massaro.